Other studies in the Myles Brown laboratory used a genome-wide approach to understand the underlying mechanism by which ERα protects breast cancer cells from the p53 apoptotic function and identified the modulation of a specific subset of p53 and ERα target genes [93]. Here, TP53 is linked to breast cancer.